Treatment of nosocomial pneumonia with piperacillin-tazobactam

A. Eatemadi, E. Eidani, M. Jahangirnejad, Z. Peymen, S. Hojabrkalali (Ahwaz, Islamic Republic Of Iran)

Source: Annual Congress 2007 - Pulmonary infections and inflammation
Session: Pulmonary infections and inflammation
Session type: Electronic Poster Discussion
Number: 480
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Eatemadi, E. Eidani, M. Jahangirnejad, Z. Peymen, S. Hojabrkalali (Ahwaz, Islamic Republic Of Iran). Treatment of nosocomial pneumonia with piperacillin-tazobactam. Eur Respir J 2007; 30: Suppl. 51, 480

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparisom between imipenem/cilastatin and cefepim for treatment of severe nosocomial pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 53s
Year: 2007

Antibiotic resistance and nosocomial pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005

New antibiotics for VAP
Source: Eur Respir Mon 2011; 53: 48-53
Year: 2011


Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Source: Eur Respir J 2007; 30: 307-313
Year: 2007



Antibiotic treatment for nosocomial pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211
Year: 2004

Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2010; 36: 128-134
Year: 2010



Tigecycline vs levofloxacin for the treatment of community-acquired pneumonia (CAP): EU experience
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Antibiotic management of nosocomial pneumonia in children
Source: Eur Respir J 2006; 28: Suppl. 50, 633s
Year: 2006

Ertapenem therapy for community-acquired pneumonia in the elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 638s
Year: 2005

Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia
Source: Eur Respir Rev 2007; 16: 33-39
Year: 2007



Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 45-49
Year: 2007



Delirium induced by clarithromycin in a patient with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 671-672
Year: 2006


Empirical treatment of community-acquired pneumonia after outpatient beta-lactam therapy
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Epidemiology of community-acquired pneumonia and nosocomial pneumonia
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006



The use of piperacillin/tazobactam for treatment of pneumonia in neutropenic patients
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010


Community-acquired pneumonia outbreaks control with azithromycin
Source: Eur Respir J 2003; 22: Suppl. 45, 148s
Year: 2003

The approach to antibiotic treatment in community-acquired pneumonia
Source: Annual Congress 2008 - MP14 - The approach to antibiotic treatment in community-acquired pneumonia
Year: 2008

Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia
Source: Annual Congress 2012 - CT findings: educational posters
Year: 2012

Eradication of MRSA ventilator-associated infection with inhaled vancomycin.
Source: International Congress 2017 – Hospital-acquired infections: from prevention to treatment
Year: 2017